• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢早衰与组织工程。

Premature ovarian failure and tissue engineering.

机构信息

Department of Tissue Engineering, Tabriz University of Medical Sciences, Tabriz, Iran.

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

J Cell Physiol. 2020 May;235(5):4217-4226. doi: 10.1002/jcp.29376. Epub 2019 Oct 29.

DOI:10.1002/jcp.29376
PMID:31663142
Abstract

Premature ovarian failure (POF) usually happens former to the age of 40 and affects the female physiological state premenopausal period. In this condition, ovaries stop working long before the expected menopausal time. Of diagnostic symptoms of the disease, one can mention amenorrhea and hypoestrogenism. The cause of POF in most cases is idiopathic; however, cancer therapy may also cause POF. Commonly utilized therapies such as hormone therapy, in-vitro activation, and regenerative medicine are the most well-known treatments for POF. Hence, these therapies may be associated with some complications. The aim of the present study is to discuss the beneficial effects of tissue engineering for fertility rehabilitation in patients with POF as a newly emerging therapy.

摘要

卵巢早衰(POF)通常发生在 40 岁之前,影响女性绝经前的生理状态。在这种情况下,卵巢在预期绝经时间之前很早就停止工作。该疾病的诊断症状包括闭经和雌激素水平低下。大多数情况下,POF 的原因是特发性的;然而,癌症治疗也可能导致 POF。常用的治疗方法,如激素治疗、体外激活和再生医学,是 POF 的最知名治疗方法。因此,这些治疗方法可能与一些并发症有关。本研究旨在讨论组织工程作为一种新兴疗法对 POF 患者生育康复的有益影响。

相似文献

1
Premature ovarian failure and tissue engineering.卵巢早衰与组织工程。
J Cell Physiol. 2020 May;235(5):4217-4226. doi: 10.1002/jcp.29376. Epub 2019 Oct 29.
2
The Roles of Different Stem Cells in Premature Ovarian Failure.不同干细胞在卵巢早衰中的作用
Curr Stem Cell Res Ther. 2020;15(6):473-481. doi: 10.2174/1574888X14666190314123006.
3
Recent scaffold-based tissue engineering approaches in premature ovarian failure treatment.基于支架的组织工程方法在卵巢早衰治疗中的应用。
J Tissue Eng Regen Med. 2022 Jul;16(7):605-620. doi: 10.1002/term.3306. Epub 2022 May 5.
4
Human mesenchymal stem cell treatment of premature ovarian failure: new challenges and opportunities.人骨髓间充质干细胞治疗卵巢早衰:新的挑战和机遇。
Stem Cell Res Ther. 2021 Mar 3;12(1):161. doi: 10.1186/s13287-021-02212-0.
5
Current approaches for the treatment of premature ovarian failure with stem cell therapy.干细胞治疗治疗卵巢早衰的当前方法。
Biomed Pharmacother. 2018 Jun;102:254-262. doi: 10.1016/j.biopha.2018.03.056. Epub 2018 Mar 22.
6
Symptoms, health behavior and understanding of menopause therapy in women with premature menopause.早发性绝经女性的症状、健康行为及对绝经治疗的认知
Climacteric. 2014 Dec;17(6):666-73. doi: 10.3109/13697137.2014.913284. Epub 2014 Jul 17.
7
Premature ovarian failure: diagnosis and treatment.卵巢早衰:诊断与治疗
Clin Exp Obstet Gynecol. 2014;41(6):659-61.
8
The Therapeutic Effect of Stem Cells on Chemotherapy-Induced Premature Ovarian Failure.干细胞对化疗诱导的卵巢早衰的治疗作用。
Curr Mol Med. 2021;21(5):376-384. doi: 10.2174/1566524020666200905113907.
9
Transplantation of ovarian granulosa‑like cells derived from human induced pluripotent stem cells for the treatment of murine premature ovarian failure.人诱导多能干细胞来源的卵巢颗粒样细胞移植治疗小鼠卵巢早衰
Mol Med Rep. 2016 Jun;13(6):5053-8. doi: 10.3892/mmr.2016.5191. Epub 2016 Apr 26.
10
Premature ovarian failure: etiology and prospects.卵巢早衰:病因及展望
Gynecol Endocrinol. 2000 Aug;14(4):292-302. doi: 10.3109/09513590009167696.

引用本文的文献

1
The quality and reliability of short videos about premature ovarian failure on Bilibili and TikTok: Cross-sectional study.哔哩哔哩和抖音上关于卵巢早衰短视频的质量与可靠性:横断面研究
Digit Health. 2025 Jun 17;11:20552076251351077. doi: 10.1177/20552076251351077. eCollection 2025 Jan-Dec.
2
The risk factors, pathogenesis and treatment of premature ovarian insufficiency.卵巢早衰的危险因素、发病机制及治疗
J Ovarian Res. 2025 Jun 18;18(1):134. doi: 10.1186/s13048-025-01714-2.
3
Preparation and characterization of human decellularized ovarian scaffold based on supercritical carbon dioxide protocol.
基于超临界二氧化碳方案的人脱细胞卵巢支架的制备与表征
Biomed Eng Online. 2025 May 13;24(1):59. doi: 10.1186/s12938-025-01392-7.
4
Yijing Decoction improves premature ovarian failure in rats by activating VEGF/VEGFR-2/FAK pathway.益母汤通过激活VEGF/VEGFR-2/FAK通路改善大鼠卵巢早衰。
J Ovarian Res. 2025 Apr 26;18(1):87. doi: 10.1186/s13048-025-01679-2.
5
Exosomes derived from hypoxic mesenchymal stem cell ameliorate premature ovarian insufficiency by reducing mitochondrial oxidative stress.缺氧间充质干细胞来源的外泌体通过降低线粒体氧化应激改善卵巢早衰。
Sci Rep. 2025 Mar 10;15(1):8235. doi: 10.1038/s41598-025-90879-3.
6
Infertility treatment using polysaccharides-based hydrogels: new strategies in tissue engineering and regenerative medicine.基于多糖的水凝胶在不孕不育治疗中的应用:组织工程与再生医学的新策略
J Nanobiotechnology. 2025 Mar 4;23(1):162. doi: 10.1186/s12951-025-03267-4.
7
3D bioprinting technology innovation in female reproductive system.女性生殖系统的3D生物打印技术创新
Mater Today Bio. 2025 Feb 4;31:101551. doi: 10.1016/j.mtbio.2025.101551. eCollection 2025 Apr.
8
Human urine stem cells protect against cyclophosphamide-induced premature ovarian failure by inhibiting SLC1A4-mediated outflux of intracellular serine in ovarian granulosa cells.人尿干细胞通过抑制卵巢颗粒细胞中SLC1A4介导的细胞内丝氨酸外流,预防环磷酰胺诱导的卵巢早衰。
Cell Mol Biol Lett. 2025 Feb 19;30(1):21. doi: 10.1186/s11658-025-00701-1.
9
Exploring the innovative application of cerium oxide nanoparticles for addressing oxidative stress in ovarian tissue regeneration.探索氧化铈纳米颗粒在解决卵巢组织再生中的氧化应激方面的创新应用。
J Ovarian Res. 2024 Dec 5;17(1):241. doi: 10.1186/s13048-024-01566-2.
10
Oncofertility and Fertility Preservation for Women with Gynecological Malignancies: Where Do We Stand Today?妇科恶性肿瘤患者的肿瘤生育学与生育力保存:我们今天处于什么位置?
Biomolecules. 2024 Aug 3;14(8):943. doi: 10.3390/biom14080943.